Gleevec be offered free to Leukemia patients

Published: 2001-05-04 06:56:00

Updated: 2001-05-04 06:56:00

At the press conference with Gleevec held at Seoul Plaza hotel on April 25, Novartis Korea Co. President Frank Bobe said, "Gleevec will be provided to patients for free in the next 2 weeks", and that its patients will be chosen after due consultation with Korea Orphan Drug Center and specialists....

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK